Lexaria Bioscience Corp. (LEXX)
 NASDAQ: LEXX · Real-Time Price · USD
 0.9835
 +0.0243 (2.53%)
  At close: Oct 30, 2025, 4:00 PM EDT
0.9503
 -0.0332 (-3.38%)
  After-hours: Oct 30, 2025, 7:55 PM EDT
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $21.87 million as of October 30, 2025. Its market cap has decreased by -54.81% in one year.
Market Cap 
 21.87M
Enterprise Value 
 17.37M
1-Year Change 
 -54.81%
Ranking 
 Category 
 Stock Price 
$0.98
Market Cap Chart
Since February 12, 2007, Lexaria Bioscience's market cap has increased from $19.40M to $21.87M, an increase of 12.75%. That is a compound annual growth rate of 0.64%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 18.80M | -48.77% | 
| Dec 31, 2024 | 36.70M | 186.72% | 
| Dec 29, 2023 | 12.80M | -12.33% | 
| Dec 30, 2022 | 14.60M | -36.80% | 
| Dec 31, 2021 | 23.10M | 2.67% | 
| Dec 31, 2020 | 22.50M | -24.75% | 
| Dec 31, 2019 | 29.90M | -58.30% | 
| Dec 31, 2018 | 71.70M | -38.87% | 
| Dec 29, 2017 | 117.30M | 624.07% | 
| Dec 30, 2016 | 16.20M | 131.43% | 
| Dec 31, 2015 | 7.00M | 125.81% | 
| Dec 31, 2014 | 3.10M | 342.86% | 
| Dec 31, 2013 | 700.00K | -12.50% | 
| Dec 31, 2012 | 800.00K | -77.78% | 
| Dec 30, 2011 | 3.60M | -7.69% | 
| Dec 31, 2010 | 3.90M | 69.57% | 
| Dec 31, 2009 | 2.30M | 130.00% | 
| Dec 31, 2008 | 1.00M | -94.71% | 
| Dec 31, 2007 | 18.90M | -2.58% | 
| Feb 12, 2007 | 19.40M | - | 
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 741.90B | 
| Johnson & Johnson | 457.53B | 
| AbbVie | 402.83B | 
| UnitedHealth Group | 331.46B | 
| AstraZeneca | 259.35B | 
| Novartis AG | 250.89B | 
| Novo Nordisk | 235.38B | 
| Abbott Laboratories | 221.35B |